BDBM50115051 1-{3-[(2R,4S)-4-Benzyl-2-((S)-1-hydroxy-pentyl)-piperidin-1-yl]-propyl}-3-[3-(1-methyl-1H-tetrazol-5-yl)-phenyl]-urea::CHEMBL50194

SMILES CCCC[C@H](O)[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(c1)-c1nnnn1C

InChI Key InChIKey=BAAFLUWVDPBRCL-MVNQZMKCSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50115051   

TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Bristol-Myers Squibb

Curated by ChEMBL
LigandPNGBDBM50115051(1-{3-[(2R,4S)-4-Benzyl-2-((S)-1-hydroxy-pentyl)-pi...)
Affinity DataIC50:  1nMAssay Description:In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed